2022 was a big year for clinical trials.  From supply chain disruptions and staffing shortages to slowing the MedTech boom of 2021, we have weathered some significant challenges.

In Episode 11 of mdtalk, host LaQuinta Jernigan, Chief Operating Officer at mdgroup, is joined by Tom Brazier, our Director of Decentralised Clinical Solutions and mdgroup’s Chief Executive Officer, Tarquin Scadding-Hunt. 

They reflect on the past year and explore their predictions and hopes for 2023.